Siblings Books/Book Section [1/1] Conference Papers/Meeting Abstract [4/5] Patents [0/27] Collection Statistics Item counts issued in 3 years:2(3.57%) Items With Fulltext:56(100.00%) Download counts of the item Download times greater than 0:56(100.00%) Download times greater than 100:54(96.43%) Total Bitstream Download Counts:36485(91.71%) Last Update: 2024-11-28 17:58 Top Upload Loading... Top Download Loading... Recent Submissions SARS-CoV-2 spike-FLIPr fusion prote... A broad-spectrum pneumococcal vacci... Truncated pneumolysin from streptoc... Domain 4 of pneumolysin from Strept... Delivery of antigen to CD8(+) dendr... A therapeutic vaccine targeting HPV... Polysorbasome: A colloidal vesicle ... Efficient uptake of recombinant lip... Identification of immunoreactive pe... Degradable emulsion as vaccine adju...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 56. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-02-01	SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters	Journal of Virology. 2024 Feb 20;98(2):Article number e0154623.
2023-12	A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge	Emerging Microbes and Infections. 2023 Dec;12(2):Article number 2272656.
2020-05-09	Truncated pneumolysin from streptococcus pneumoniae as a TLR4-Antagonizing new drug for chronic inflammatory conditions	Cells. 2020 May 9;9(5):Article number 1183.
2019-10	Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity	Biochemical and Biophysical Research Communications. 2019 Oct;517(4):596-602.
2019-08-02	Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity	Frontiers in Immunology. 2019 Aug 2;10:Article number 1839.
2018-12-25	Identification of immunoreactive peptides of toxins to simultaneously assess the neutralization potency of antivenoms against neurotoxicity and cytotoxicity of naja atra venom	Toxins. 2018 Dec 25;10(1):Article number 10.
2018-12	A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity	American Journal of Cancer Research. 2018 Dec;8(12):2528-2537.
2018-04-23	Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity	Frontiers in Immunology. 2018 Apr 23;9:Article number 822.
2018-04-18	Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery	ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
2016-11-09	Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy	Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-07-29	Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice	Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07	The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection	Human Vaccines and Immunotherapeutics. 2016 Jul;12(7):1678-1689.
2016-05-06	A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity	Journal of Controlled Release. 2016 May 6;233:57-63.
2016-05	A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population	Oncotarget. 2016 May;7(21):30804-30819.
2016-04	Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity	Scientific Reports. 2016 Apr;6:Article number 24199.
2016-03	S. cerevisiae Mre11 recruits conjugated SUMO moieties to facilitate the assembly and function of the Mre11-Rad50-Xrs2 complex	Nucleic Acids Research. 2016 Mar;44(5):2199-2213.
2016-02	Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice	Vaccine. 2016 Feb;34(8):1054-1061.
2015-12-29	The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice	PLoS ONE. 2015 Dec 29;10(12):Article number e0145717.
2015-12	Recombinant bacterial lipoproteins as vaccine candidates	Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
2015-10	Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy	OncoImmunology. 2015 Oct 29;5(3):e1095433.
2015-08-13	Biochemical and immunological characterization of truncated fragments of the receptor-binding domains of C. difficile toxin A	PLoS ONE. 2015 Aug 13;10(8):Article number e0135045.
2015-08-07	Recombinant lipoprotein-based vaccine candidates against C. difficile infections	Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-03	Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: Potential clinical impact	Expert Review of Vaccines. 2015 Mar;14(3):383-394.
2014-05	Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells	Journal of Immunology. 2014 May;192(9):4233-4241.
2014-03-19	Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy	Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03	Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity	Vaccine. 2014 Mar;32(12):1346-1353.
2014-03	A purified recombinant lipopeptide as adjuvant for cancer immunotherapy	BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-01	A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity	Journal of Controlled Release. 2014 Jan;173(1):158-165.
2014-01	Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide	Biomaterials. 2014 Jan;35(5):1686-1695.
2013-09-19	Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement	PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09	Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III	Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07	A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates	Archives of Virology. 2013 Jul;158(7):1523-1531.
2012-07	Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model	PLoS ONE. 2012 Jul;7(7):Article number e40970.
2012-05	Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses	PLoS Neglected Tropical Diseases. 2012 May;6(5):Article number e1645.
2012-02	Influence of medium components on the expression of recombinant lipoproteins in Escherichia coli	Applied Microbiology and Biotechnology. 2012 Feb;93(4):1539-1552.
2011-08	Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo	Journal of Leukocyte Biology. 2011 Aug;90(2):323-332.
2011-08	A novel single-dose dengue subunit vaccine induces memory immune responses	PLoS ONE. 2011 Aug;6(8):Article number e23319.
2011-07	Rapid Isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis	Proteomics. 2011 Jul;11(13):2620-2627.
2010-11	Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B	Vaccine. 2010 Nov;28(51):8175-8182.
2010-11	Generating stable chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development	Biotechnology Progress. 2010 Nov;26(6):1733-1740.
2010-09	Enhancement of specific cell-capture efficiency using a reversible dielectrophoresis field	Sensors and Actuators, A: Physical. 2010 Sep;163(1):128-137
2010-08	Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice	PLoS ONE. 2010 Aug;5(8):Article number e12279.
2010-07	A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide	Molecular Immunology. 2010 Jul;47(11-12):2015-2021.
2009-11-01	Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization	Cancer Biology and Therapy. 2009 Nov 1;8(21):2025-2032.
2009-09-04	Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses	Vaccine. 2009 Sep 4;27(40):5460-5471.
2009-08	Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)	Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009 Aug;90(2):832-841.
2009-08	Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant	Pharmaceutical Research. 2009 Aug;26(8):1856-1862.
2009-05-22	Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus	Biochemical and Biophysical Research Communications. 2009 May 22;383(1):27-31.
2009-05	Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine	Microbes and Infection. 2009 May;11(6-7):654-660.

Showing items 1-50 of 56. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page